Found 85 clinical trials
Study to Assess the Efficacy Safety and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)
Primary Objective: Primary population (former smokers cohort): Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Primary population (former smokers cohort): Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former …
- 662 views
- 27 Sep, 2022
- 58 locations
A 24-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in subjects with chronic obstructive pulmonary disease (COPD)
A 24-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in subjects with chronic obstructive pulmonary disease (COPD)
- 615 views
- 25 Mar, 2021
- 1 location
Do you have Chronic Obstructive Pulmonary Disease also known as COPD?
Do you have Chronic Obstructive Pulmonary Disease also known as COPD?
- 252 views
- 23 Nov, 2020
- 1 location
Breathe New Life into COPD Research!
Breathe New Life into COPD Research!
- 376 views
- 08 Nov, 2020
- 1 location
Improving Communication and Healthcare Outcomes for Patients With Communication Disabilities
In the United States, 14% of all adults report a speech, language, voice, and/or hearing disability (collectively known as communication disabilities, CD). Patients with CD, experience inequities in receipt of and access to high-quality healthcare services, including primary care. Poor patient-provider communication is a significant contributor to these disparities. When …
- 0 views
- 23 Mar, 2022
- 2 locations
LVRS Versus BLVR in Patients With Homogenous Emphysema CLUB-HE Trial
This is a prospective randomized clinical trial comparing surgical and bronchoscopic lung volume reduction in patients with advanced homogeneous emphysema suitable for both procedures.
- 0 views
- 03 Oct, 2021
- 1 location